2. Executive Summary
The raw material for blood plasma industry is the liquid that is a component of blood called blood plasma. Blood
plasma makes up approximately 55% of the total blood volume. Blood plasma is pale yellow in color and consists
of water, proteins and salt. Those proteins are used to produce medicinal products for treatment of a variety of
life-threatening diseases, illnesses and conditions. These plasma-derived medications are the standard course of
treatment for thousands of people, in more than 100 countries across the globe, who need the treatment to
improve their health and lead productive lives.
The chief components of the global blood plasma market are immunoglobulin, albumin, factor VIII and Alpha-1
proteinase inhibitor (A1PI) or alpha-1 antitrypsin (AAT). These components are proteins and antibodies that are
extracted from the fractionated blood plasma and used for the treatment of various indications.
The key factors which are anticipated to drive this market include rising healthcare expenditure, growing demand
for polyvalent immunoglobulin and increasing market for albumin in the Asia-pacific. Some of the noteworthy
progresses of this industry include the new potential for raising AATD diagnosis and introduction of extended
half-life products for hemophilia. However, the growth of respective industry is challenged by the high cost of
production that discourages new entrants, shrinking market for plasma-derived factor VIII, high industry
regulation in the emerging market and increasing threat of substitutes.
The report provides a wide-ranging study of global blood plasma market and also major regional markets.
Furthermore, market dynamics such as key trends and development; and challenges are examined in depth. The
global blood plasma market is highly competitive consisting of several large conglomerates including Baxter
international, CSL, Grifols, Octapharma etc. The competitive landscape of the respective market, along with the
company profiles of the leading players are also discussed in detail.
View Report Details
3. The global blood plasma market consists of several plasma-derived products, primarily proteins that help
treating various rare and congenital diseases as well as deficiencies in the human body.
• The global blood plasma market revenue for the year
2015 is noted to be US$xxx billion. The market revenue is
set to grow at a CAGR of xx.0x% over the period
spanning 2015-2018, attaining a value of nearly US$xxx
billion in the year 2018.
• The global immunoglobulin market has grown by nearly
xx% over the previous year due to growth in volume and a
stable price environment. It is forecasted that the market
revenue will grow at a CAGR of xx.x% over the period
spanning 2015-2018, reaching nearly US$xxx billion by
the end of 2018.
• The global albumin market revenue reached US$xxx
billion in the year 2015, marking a growth of ….% from the
previous year. It is forecasted that the revenue will
continue to grow further at a CAGR …% over the period
2015-2018F
Global Immunoglobulin Market Revenue (2013-2018F)
Global Blood Plasma Market Revenue (2013-2018F)
Global Albumin Market Revenue (2013-2018F)
2013 2014 2015 2016F 2017F 2018F
US$Billion
2013 2014 2015 2016F 2017F 2018F
US$Billion
2013 2014 2015 2016F 2017F 2018F
US$Billion
4. The US has one of the largest markets for immunoglobulin in the world, accounting to nearly half of the
global immunoglobulin revenue
• The US blood plasma fractionation capacity has witnessed a gradual
growth over time. In the year 2014, the US plasma fractionation
capacity was recorded to be xxx million litres and it is estimated to
have risen to xxx5 million litres in the year 2015.
• The US immunoglobulin revenue for 2014 was recorded to be US$xx
billion and is estimated to be US$xx billion for the year 2015,
witnessing an expected growth of ….%. Besides, it is forecasted that
this revenue shall continue to grow further at a CAGR of ….% during
the period 2015-2018.
• The US immunoglobulin sales volume in the year 2014 was recorded
to be xx million grams and it has increased in the next year, adding up
to xx million grams.
The US Immunoglobulin Market Revenue (2013-2018F)
The US Plasma Fractionation Capacity – Actuals (2012-2015E)
The US Immunoglobulin Market by Volume (2013-2020F)
2012 2013 2014 2015E
MillionLitres
2013 2014 2015E 2016F 2017F 2018F
US$Billion
2013 2014 2015 2016F 2017F 2018F 2019F 2020F
MillionGrams
5. The human albumin market accounts for more than half of the plasma product market in China.
• China is one of the largest markets globally for plasma products.
In 2014, the total market size of plasma products was valued at
US$xx billion, which is estimated to have risen to US$xx billion in
the year 2015.
• The market revenue of human albumin reached US$xxx billion in
2014 and is estimated to have increased to US$xxx billion in the
year 2015. The revenue is anticipated to increase to US$xx
billion by the end of 2020.
• The revenue from IG market in China was recorded to be
US$xxx million in 2014, which is estimated to have risen to
US$xxx million in 2015. The revenue is forecasted to grow at a
CAGR of xx% over the period 2015-2020
China Human Albumin Market Revenue (2013-2020F)
China Blood Plasma Market Revenue (2014-2020F)
China Immunoglobulin Market Revenue (2014-2020F)
2014 2015E 2016F 2017F 2018F 2019F 2020F
US$Billion
2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
US$Billion
2014 2015E 2016F 2017F 2018F 2019F 2020F
US$Million
6. Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Blood Plasma Market ”. To
know more about this report or for any customized research requirement, please contact the following:
View Report Details